Journal article
High compared with standard dose lipase pancreatic supplement.
PJ Robinson, A Olinsky, AL Smith, SB Chitravanshi
Archives of Disease in Childhood | BMJ PUBLISHING GROUP | Published : 1989
DOI: 10.1136/adc.64.1.143
Abstract
Cotazym-S-Forte, a new pancreatic supplement containing 10,000 BP units of lipase activity per capsule, was compared with a standard dose pancreatin supplement (Pancrease) with 5000 BP units lipase activity in a randomised crossover trial. The number of capsules of Cotazym-S-Forte administered was half the usual number of Pancrease capsules and was associated with the same degree of fat absorption as Pancrease.